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Yam mosaic virus (YMV) is one of the most economically important virus infecting yams. 
Immunoassays are routinely used for laboratory diagnosis of YMV and for certification of planting 
materials. However, YMV antibodies, the key reagents, needed for these immunoassays are not readily 
available. We describe in this paper, the production of YMV monoclonal antibodies for the detection of 
YMV. The monoclonal antibody was produced by immunizing six weeks old BALB/c mice with YMV 
hybridoma cells and tapping soft peritoneal tumor tissues for antibody. Antibody titre was determined 
by triple antibody sandwich-enzyme-linked immunosorbent assay (TAS-ELISA) using YMV infected yam 
leaves and non-infected tissue culture yam leaves. The antibody produced had a titre of 1:1,310,720 and 
an optimal TAS-ELISA detection dilution of 1:80,000. This high-titre YMV monoclonal antibody is useful 
for monitoring and certification purposes.  
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INTRODUCTION 
 
Millions of people in Africa depend on yam for food each 
day (FAO, 2009). Rural farmers also rely on proceeds 
from the sales of yam tubers for the economic 
sustenance of their families. Yam production is however 
threatened by a myriad of problems such as cost and 
unavailability of planting materials, cost of labor, weeds, 
storage problems, pests and diseases, (Ezeh, 1998). 
Important yam pests include nematodes, beetles, 
termites, weevils, scale insects and rodents while 
diseases include those caused by fungi, bacteria and 
viruses (Onwueme and Charles, 1994; Hughes et al., 
1997; Asare-Bediako et al., 2007). Yam viruses, which 
occurs both in single and mixed infections, reduce tuber 
yield and quality thus reducing both the economic value 
of the important tuber, its marketability and availability for 
food (Thouvenel and Dumont, 1990; Hughes et al., 1997; 
Odu et al., 2004; Eni et al., 2010).  
Yam mosaic virus (YMV) is one of  the  most  important 
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economically important viruses infecting yam. YMV has 
been reported to be widespread in all yam producing 
countries around the world (Goudou-Urbino et al., 1996; 
Kenyon et al., 2001; Lebas, 2002; Eni et al., 2008). As 
yams are cultivated through vegetative planting materials 
(seed yam or planting sets), which accumulate viruses 
over time, management of YMV is best implemented 
through the use of certified healthy planting material. 
YMV certification depends heavily on the availability of 
sensitive and specific diagnostics. Enzyme-linked 
immunosorbent assay (ELISA) is a very useful tool for 
YMV certification. ELISA is rapid, specific and allows for 
several samples to be tested simultaneously (Cho, 1990). 
Like all immunoassays, ELISA utilizes the ability of 
antibodies to bind to the specific virus of interest thus 
antibodies remain the most critical reagent needed for 
ELISA.  
Three antibody types commonly in use are polyclonal, 
monoclonal and recombinant antibodies (Peruski and 
Peruski, 2003). While each type of antibody has its own 
merits and demerits in terms of generation, cost and 
overall   utility,   monoclonal  and  recombinant  antibodies  
  
 
 
have the potential of unlimited supply of uniform antibody. 
Monoclonal antibodies are also more specific particularly 
where strain differences exist (Matthews, 1991; Brattey 
and Burns, 1998).  
Monoclonal antibodies can be produced both by in-vitro 
and in-vivo techniques, each with its concomitant advan-
tages and disadvantages, however, most commercially 
available systems for in-vitro production of monoclonal 
antibodies, such as standard tissue culture techniques, 
are prohibitively expensive, requiring intensive training on 
cell culture techniques and the concentrations of the 
monoclonal antibodies produced are usually low 
(between 0.01 to 0.05 mg/ml) and sometimes requiring 
further concentration (Lang et al., 1991).  
Ascetic fluid is an intraperitoneal fluid extracted from 
mice peritoneal tumors. High-titre monoclonal antibody 
(mAb) production can be accomplished by injecting 
commercially available mAb-producing hybridomas into 
the peritoneum of mice, which serves as a growth 
chamber for the cells. The hybridoma cells grow to high 
densities and continue to secrete the antibody of interest, 
thus, creating a high-titered (0.5 to 5.0 mg/ml) solution of 
monoclonal antibodies for collection. This paper reports 
the production of a sensitive, high titre YMV monoclonal 
antibody in mice peritoneum.  
 
 
MATERIALS AND METHODS 
 
Production of ascetic fluid  
 
BALB/c mice, YMV hybridoma cells and YMV polyclonal antibodies 
used for this work were from the International Institute of Tropical 
Agriculture (IITA), Ibadan, Nigeria. 
Ascetic fluid production followed the method by Jackson et al. 
(1999) with slight modifications. Six weeks old BALB/c mice were 
primed by injecting 0.3 ml of incomplete Freund’s adjuvant into the 
peritoneum of each mouse. Two weeks after priming, rapidly 
growing YMV hybridoma cells in growth media were collected by 
centrifuging at 1,000 rpm for 10 min. The collected cells were 
washed once by mixing gently in phosphate buffered saline (PBS) 
and centrifuging for 1,000 rpm for 10 min. Two mice were injected 
with 5 × 106 washed hybridoma cells in 0.3 ml PBS intra-
peritoneally. After the injection, the mice were monitored daily for 
tumour formation and abdominal distension.  
Soft abdominal tumours were tapped for acetic fluid collection 
two week after injection of hybridoma cells. The abdominal surface 
of each mouse was disinfected using 70% ethanol and then a 22-
gauge syringe needle was inserted into the lower abdomen, 
dripping acetic fluid was collected into sterile BD Falcon tubes. The 
fluid was centrifuged at 1,000 rpm for 10 min in a microcentrifuge 
tube and the supernatant was carefully removed from the cell pellet 
and stored at -4°C.  
 
 
Antibody titration 
 
The titre of the monoclonal antibody produced was determined by 
triple antibody-sandwich (TAS-ELISA) as described by Thottappilly 
et al. (1998) with slight modifications. For enhanced antigen 
trapping, wells of microtitre plates were coated with 100 µl of YMV 
polyclonal antibodies (from the antibody bank of the Virology Unit of  
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the IITA) diluted 1:1000 in coating buffer (0.05 M sodium carbonate 
buffer, pH 9.6). Following two-hour incubation at 37°C, the plates 
were washed three times at three minutes intervals using 
phosphate buffered-saline (137.00 mM NaCl, 1.46 mM KH2PO4, 
7.75 mM Na2HPO4, 2.68 mM KCl, pH 7.4.) containing 0.05 % (v/v) 
Tween-20 (PBS-T). The wells were then blocked by incubating 200 
µl of 5% skimmed milk powder (Marvel) in each well for 1 h at 37°C. 
Leaf sap extract (200 µl) prepared by grinding either the healthy or 
YMV-infected yam leaves in grinding buffer (PBS-T, 0.5 mM 
polyvinyl pyrrolidone (PVP)-40 and 79.4 mM Na2SO3) was loaded 
into 36 wells each and incubated overnight at 4°C. A two fold serial 
dilution of the produced YMV monoclonal antibody was made in 
PBS-T and 100 µl of each dilution was added to duplicate wells pre-
coated either with healthy or infected leaf sap and the plates were 
incubated at 37°C for 2 h. After the washing step, 100 µl of goat 
anti-mouse alkaline phosphatase diluted at 1:40,000 in conjugate 
buffer (half strength PBS containing 0.05% (v/v) Tween-20, 0.02% 
(w/v) egg albumin, 0.005 mM PVP-40) was added to each well and 
incubated at 37°C for 2 h. Then 200 µl of ρ-nitrophenylphosphate 
substrate (ρNPP) (1 mg ml-1 in 10% diethanolamine, pH 9.8) was 
added into each of the wells to detect the antigen-antibody 
reactions.  
 
 
RESULTS AND DISCUSSION 
 
Titration of YMV ascetic fluid 
 
BALB/c mice were used for this study to ensure 
histocompatibility with the YMV hybridoma cells used for 
this work. The mouse cell line used as hybridoma fusion 
partners for the production of the YMV hybridoma cells 
used were derived from BALB/c mice (Njukeng et al., 
2002), thus, the use of a different strain of mouse may 
have result in the rejection of the injected cells and 
consequently an inability to produce the desired antibody. 
Successful use of inter-strain hybridomas for ascetic fluid 
production have however been reported, in such cases, 
immunedeficient or immunesuppressed mouse were 
used.  
Two commonly used priming solutions in ascetic fluid 
production are pristane (2,6,10,14-tetramethyldecanoic 
acid) and incomplete Freund's adjuvant (Gillette, 1987). 
These solutions act as irritants to the mice, which 
respond by secreting nutrients and recruiting monocyte 
and lymphoid cells into the abdominal area, thus, creating 
a good environment for the growth of the introduced 
hybridoma cells. Incomplete Freund’s adjuvant was used 
for this work because it has been suggested to have less 
adverse effects on the animals than pristane. Further-
more, besides causing less discomfort to the animal, 
incomplete Freund’s adjuvant has been demonstrated to 
be better than pristane as a priming agent (Mueller et al., 
1986; Gillette, 1987; Jones et al., 1990). 
The two mice used in our work remained well during 
the experiments although, a marked reduction in their 
movement was observed as the experiment progressed. 
Approximately, 3 ml of ascetic fluid was collected from 
each mouse.  
For antibody titration by TAS-ELISA, a reaction is 
considered to be positive if the  detection  factor  (ratio  of 
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Figure 1. Detection of Yam mosaic virus (YMV) in infected and healthy yam sap by triple antibody sandwich enzyme-
linked immunosorbent assay (TAS-ELISA) using serially diluted monoclonal antibody. A405 of infected sap/A405 of healthy 
sap ratio > 2 is considered to be positive. 
 
 
 
the mean absorbance value of the infected sap and the 
healthy sap) at that dilution is greater than 2 (Thottappilly 
et al., 1998).  
 
                                             Mean A405 of infected sap 
Detection factor =  
                                  Mean A405 of healthy sap 
 
 
Positive reactions were observed from 1:640 dilutions 
with a detection factor of 2 and peaked at 1:10,240 with a 
detection factor of 8.2. Subsequent monoclonal antibody 
dilutions detected YMV in infected sap but, with declining 
detection factors and detection continued to the last 
antibody dilution of 1:1,310,720 (Figure 1). Noting that 
the detection factor remained very close to the peak 
between 1:10,240 and 1:81,920 dilutions (8.2 to 7.9), the 
optimal TAS-ELISA working dilution for this antibody can 
be stretched as far as 1:80,000.  
Although, the volume of monoclonal antibody produced 
was low, this is adequately compensated for by the high 
titre of the antibody. The optimal TAS-ELISA working 
dilution of most available in-vitro produced YMV 
monoclonal antibodies 1:500 which is way lower than  
1:80,000 obtained for the current antibody. This high titre 
is also economically significant particularly considering 
the cost and time that would be required to produce a 
similar total TAS-ELISA ready-to-use dilution of YMV 
monoclonal antibody in-vitro.  
The YMV monoclonal antibody produced in this study 
would boost current efforts to reduce the spread of YMV 
through enhanced monitoring and certification. Such 
monitoring and certification activities are continuously 
ongoing at the International Institute of Tropical 
Agriculture (IITA) and other international and National 
Agricultural Research Institutes/Stations worldwide, most 
of which depends on IITA for YMV antibody supply, yam 
being one of the IITA mandate crops.  
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